Knowledge | NT Scan During Pregnancy: Understanding Risk Assessment for Down Syndrome and Other Genetic Disorders
During pregnancy, doctors may recommend an NT (nuchal translucency) scan. This is a non-invasive ultrasound screening test primarily used to assess the risk of the fetus having Down syndrome and other genetic disorders. The NT scan is usually scheduled between 11 and 14 weeks of pregnancy, providing key reference information for health management during pregnancy.
What is an NT scan?
An NT scan is a test that uses ultrasound to measure the thickness of the nuchal translucency (the fluid-filled space at the back of the fetal neck) to assess the risk of the fetus having genetic disorders. During the examination, blood tests may also be combined to analyze the levels of the following specific hormones and proteins:
Free beta-human chorionic gonadotropin (beta-hCG)
Pregnancy-associated plasma protein A (PAPP-A)
Alpha-fetoprotein (AFP)
Abnormal levels of these hormones and proteins may indicate a risk of genetic disorders in the fetus. The combination of the NT scan and blood tests is called the "first-trimester combined screening."
Disease risks assessed by the NT scan
The amount of fluid accumulating in the nuchal translucency of the fetus may be abnormally increased, which may be associated with the following conditions:
Down syndrome (trisomy 21): A genetic disorder caused by an extra copy of chromosome 21, leading to intellectual and physical developmental disabilities, birth defects, and health problems.
Trisomy 13 and trisomy 18: An extra copy of chromosome 13 or 18 causes severe birth defects and intellectual disability, and often leads to early death.
Turner syndrome: Caused by a complete or partial absence of one X chromosome, this condition affects fetuses with an X sex chromosome, leading to growth problems and defects of the heart and ovaries.
Congenital heart defects: Congenital heart defects can cause abnormal blood flow in the heart, and some cases may be life-threatening.
It should be clarified that the NT scan cannot diagnose the aforementioned diseases; it can only indicate whether the fetus may have a higher or lower risk of these conditions.
The NT scan procedure
The NT scan is a routine ultrasound examination. The bladder needs to be full before the test; pregnant women are usually required to drink 2 to 3 cups of water one hour before the examination and avoid urinating.
During the examination, the pregnant woman lies flat on the examination bed. The sonographer will apply conductive gel to the abdomen and then move an ultrasound probe over the abdomen to capture images. After the examination, the images will be analyzed by a radiologist and sent to the attending physician.
Safety of the NT scan
The NT scan is a safe, non-invasive test with no known risks. During the examination, mild pressure from the probe on the abdomen may be felt; this sensation is normal.
Is the NT scan necessary?
The NT scan is an optional screening tool. Its advantage is that it can provide preliminary results early in pregnancy, offering reference information for expectant parents to plan for the future. Pregnant women may also choose not to undergo this test, especially if the results would not affect pregnancy management.
Interpreting NT scan results
The thickness of the fetal nuchal translucency changes as the fetus grows. The normal range is within 2 mm at 11 weeks and within 2.8 mm at 13 weeks and 6 days. Measurements exceeding this range may indicate a higher risk of genetic disorders.
Doctors will evaluate the results by combining the measurement value, the pregnant woman's age, and blood test results. The combination of the NT scan and blood tests can predict genetic disorders with an accuracy of 85%, but approximately 5% of results may be false positives.
Response to abnormal results
If the NT scan results are abnormal, the doctor may recommend further tests, including:
Chorionic villus sampling: Extraction of placental tissue for analysis.
Amniocentesis: Extraction of an amniotic fluid sample to test fetal chromosomes.
Non-invasive prenatal testing (cfDNA): Analysis of fetal DNA from the pregnant woman's blood.
These tests may carry a risk of miscarriage. The doctor will explain the risks and benefits in detail to help expectant parents make decisions.
Summary
The NT scan is a safe, routine, and optional ultrasound screening tool that can help predict the likelihood of the fetus having genetic disorders such as Down syndrome. Expectant parents can decide whether to undergo this test based on their own needs.
Story source: Collected from the internet
Author LinkedIVF TeamPublished 2024-11-24
This article used AI assistance; LinkedIVF has not recorded an editorial review for this item. It is not medical advice.
This content is for informational purposes only and does not constitute medical advice. Please consult a licensed physician. Content guidelines & editorial policy
Knowledge | NT Screening During Pregnancy: Assessing the Risk of Down Syndrome and Other Genetic Conditions
Knowledge | NT Scan During Pregnancy: Understanding Risk Assessment for Down Syndrome and Other Genetic Disorders
During pregnancy, doctors may recommend an NT (nuchal translucency) scan. This is a non-invasive ultrasound screening test primarily used to assess the risk of the fetus having Down syndrome and other genetic disorders. The NT scan is usually scheduled between 11 and 14 weeks of pregnancy, providing key reference information for health management during pregnancy.
What is an NT scan?
An NT scan is a test that uses ultrasound to measure the thickness of the nuchal translucency (the fluid-filled space at the back of the fetal neck) to assess the risk of the fetus having genetic disorders. During the examination, blood tests may also be combined to analyze the levels of the following specific hormones and proteins:
Free beta-human chorionic gonadotropin (beta-hCG)
Pregnancy-associated plasma protein A (PAPP-A)
Alpha-fetoprotein (AFP)
Abnormal levels of these hormones and proteins may indicate a risk of genetic disorders in the fetus. The combination of the NT scan and blood tests is called the "first-trimester combined screening."
Disease risks assessed by the NT scan
The amount of fluid accumulating in the nuchal translucency of the fetus may be abnormally increased, which may be associated with the following conditions:
Down syndrome (trisomy 21): A genetic disorder caused by an extra copy of chromosome 21, leading to intellectual and physical developmental disabilities, birth defects, and health problems.
Trisomy 13 and trisomy 18: An extra copy of chromosome 13 or 18 causes severe birth defects and intellectual disability, and often leads to early death.
Turner syndrome: Caused by a complete or partial absence of one X chromosome, this condition affects fetuses with an X sex chromosome, leading to growth problems and defects of the heart and ovaries.
Congenital heart defects: Congenital heart defects can cause abnormal blood flow in the heart, and some cases may be life-threatening.
It should be clarified that the NT scan cannot diagnose the aforementioned diseases; it can only indicate whether the fetus may have a higher or lower risk of these conditions.
The NT scan procedure
The NT scan is a routine ultrasound examination. The bladder needs to be full before the test; pregnant women are usually required to drink 2 to 3 cups of water one hour before the examination and avoid urinating.
During the examination, the pregnant woman lies flat on the examination bed. The sonographer will apply conductive gel to the abdomen and then move an ultrasound probe over the abdomen to capture images. After the examination, the images will be analyzed by a radiologist and sent to the attending physician.
Safety of the NT scan
The NT scan is a safe, non-invasive test with no known risks. During the examination, mild pressure from the probe on the abdomen may be felt; this sensation is normal.
Is the NT scan necessary?
The NT scan is an optional screening tool. Its advantage is that it can provide preliminary results early in pregnancy, offering reference information for expectant parents to plan for the future. Pregnant women may also choose not to undergo this test, especially if the results would not affect pregnancy management.
Interpreting NT scan results
The thickness of the fetal nuchal translucency changes as the fetus grows. The normal range is within 2 mm at 11 weeks and within 2.8 mm at 13 weeks and 6 days. Measurements exceeding this range may indicate a higher risk of genetic disorders.
Doctors will evaluate the results by combining the measurement value, the pregnant woman's age, and blood test results. The combination of the NT scan and blood tests can predict genetic disorders with an accuracy of 85%, but approximately 5% of results may be false positives.
Response to abnormal results
If the NT scan results are abnormal, the doctor may recommend further tests, including:
Chorionic villus sampling: Extraction of placental tissue for analysis.
Amniocentesis: Extraction of an amniotic fluid sample to test fetal chromosomes.
Non-invasive prenatal testing (cfDNA): Analysis of fetal DNA from the pregnant woman's blood.
These tests may carry a risk of miscarriage. The doctor will explain the risks and benefits in detail to help expectant parents make decisions.
Summary
The NT scan is a safe, routine, and optional ultrasound screening tool that can help predict the likelihood of the fetus having genetic disorders such as Down syndrome. Expectant parents can decide whether to undergo this test based on their own needs.
Story source:
Collected from the internet